<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-04-18" modified="2017-11-22" version="145">
<accession>Q9NS56</accession>
<accession>O43273</accession>
<accession>Q6P987</accession>
<accession>Q9NS55</accession>
<accession>Q9UNR9</accession>
<name>TOPRS_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 ubiquitin-protein ligase Topors</fullName>
<ecNumber>2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="29">RING-type E3 ubiquitin transferase Topors</fullName>
</alternativeName>
<alternativeName>
<fullName>SUMO1-protein E3 ligase Topors</fullName>
</alternativeName>
<alternativeName>
<fullName>Topoisomerase I-binding RING finger protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Topoisomerase I-binding arginine/serine-rich protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Tumor suppressor p53-binding protein 3</fullName>
<shortName>p53-binding protein 3</shortName>
<shortName>p53BP3</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">TOPORS</name>
<name type="synonym">LUN</name>
<name type="synonym">TP53BPL</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Nucleic Acids Res." volume="27" first="2538" last="2544">
<title>Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein.</title>
<authorList>
<person name="Haluska P. Jr."/>
<person name="Saleem A."/>
<person name="Rasheed Z."/>
<person name="Ahmed F."/>
<person name="Su E.W."/>
<person name="Liu L.F."/>
<person name="Rubin E.H."/>
</authorList>
<dbReference type="PubMed" id="10352183"/>
<dbReference type="DOI" id="10.1093/nar/27.12.2538"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH TOP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="14004" last="14013">
<title>Cloning and characterization of LUN, a novel RING-finger protein that is highly expressed in lung and specifically binds to a palindromic sequence.</title>
<authorList>
<person name="Chu D."/>
<person name="Kakazu N."/>
<person name="Gorrin-Rivas M.J."/>
<person name="Lu H.P."/>
<person name="Kawata M."/>
<person name="Abe T."/>
<person name="Ueda K."/>
<person name="Adachi Y."/>
</authorList>
<dbReference type="PubMed" id="11278651"/>
<dbReference type="DOI" id="10.1074/jbc.M010262200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>PUTATIVE DNA-BINDING</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS THR-154; LYS-517 AND ASP-749</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="Gene" volume="235" first="93" last="101">
<title>Identification of a novel gene encoding a p53-associated protein.</title>
<authorList>
<person name="Zhou R."/>
<person name="Wen H."/>
<person name="Ao S.-Z."/>
</authorList>
<dbReference type="PubMed" id="10415337"/>
<dbReference type="DOI" id="10.1016/S0378-1119(99)00203-6"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 51-1045 (ISOFORM 1)</scope>
<scope>INTERACTION WITH TP53</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2002" name="Exp. Cell Res." volume="277" first="152" last="160">
<title>The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies.</title>
<authorList>
<person name="Rasheed Z.A."/>
<person name="Saleem A."/>
<person name="Ravee Y."/>
<person name="Pandolfi P.P."/>
<person name="Rubin E.H."/>
</authorList>
<dbReference type="PubMed" id="12083797"/>
<dbReference type="DOI" id="10.1006/excr.2002.5550"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="Exp. Cell Res." volume="290" first="13" last="27">
<title>The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation.</title>
<authorList>
<person name="Weger S."/>
<person name="Hammer E."/>
<person name="Engstler M."/>
</authorList>
<dbReference type="PubMed" id="14516784"/>
<dbReference type="DOI" id="10.1016/S0014-4827(03)00292-1"/>
</citation>
<scope>INTERACTION WITH SUMO1 AND UBE2I</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUMOYLATION</scope>
<scope>MUTAGENESIS OF LYS-76; LYS-301; LYS-485; LYS-560 AND LYS-921</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="36440" last="36444">
<title>Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.</title>
<authorList>
<person name="Rajendra R."/>
<person name="Malegaonkar D."/>
<person name="Pungaliya P."/>
<person name="Marshall H."/>
<person name="Rasheed Z."/>
<person name="Brownell J."/>
<person name="Liu L.F."/>
<person name="Lutzker S."/>
<person name="Saleem A."/>
<person name="Rubin E.H."/>
</authorList>
<dbReference type="PubMed" id="15247280"/>
<dbReference type="DOI" id="10.1074/jbc.C400300200"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF TRP-131</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Lung Cancer" volume="46" first="21" last="28">
<title>Expression of LUN gene that encodes a novel RING finger protein is correlated with development and progression of non-small cell lung cancer.</title>
<authorList>
<person name="Oyanagi H."/>
<person name="Takenaka K."/>
<person name="Ishikawa S."/>
<person name="Kawano Y."/>
<person name="Adachi Y."/>
<person name="Ueda K."/>
<person name="Wada H."/>
<person name="Tanaka F."/>
</authorList>
<dbReference type="PubMed" id="15364129"/>
<dbReference type="DOI" id="10.1016/j.lungcan.2004.03.009"/>
</citation>
<scope>REDUCED EXPRESSION IN LUNG CANCERS</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="5293" last="5300">
<title>The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor.</title>
<authorList>
<person name="Saleem A."/>
<person name="Dutta J."/>
<person name="Malegaonkar D."/>
<person name="Rasheed F."/>
<person name="Rasheed Z."/>
<person name="Rajendra R."/>
<person name="Marshall H."/>
<person name="Luo M."/>
<person name="Li H."/>
<person name="Rubin E.H."/>
</authorList>
<dbReference type="PubMed" id="15107820"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207700"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>REDUCED EXPRESSION IN COLON CANCERS</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="FEBS Lett." volume="579" first="5007" last="5012">
<title>Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.</title>
<authorList>
<person name="Weger S."/>
<person name="Hammer E."/>
<person name="Heilbronn R."/>
</authorList>
<dbReference type="PubMed" id="16122737"/>
<dbReference type="DOI" id="10.1016/j.febslet.2005.07.088"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUMOYLATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="3385" last="3396">
<title>Topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.</title>
<authorList>
<person name="Lin L."/>
<person name="Ozaki T."/>
<person name="Takada Y."/>
<person name="Kageyama H."/>
<person name="Nakamura Y."/>
<person name="Hata A."/>
<person name="Zhang J.H."/>
<person name="Simonds W.F."/>
<person name="Nakagawara A."/>
<person name="Koseki H."/>
</authorList>
<dbReference type="PubMed" id="15735665"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208554"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="Am. J. Hum. Genet." volume="81" first="1098" last="1103">
<title>Mutations in TOPORS cause autosomal dominant retinitis pigmentosa with perivascular retinal pigment epithelium atrophy.</title>
<authorList>
<person name="Chakarova C.F."/>
<person name="Papaioannou M.G."/>
<person name="Khanna H."/>
<person name="Lopez I."/>
<person name="Waseem N."/>
<person name="Shah A."/>
<person name="Theis T."/>
<person name="Friedman J."/>
<person name="Maubaret C."/>
<person name="Bujakowska K."/>
<person name="Veraitch B."/>
<person name="El-Aziz M.M.A."/>
<person name="Prescott de Q."/>
<person name="Parapuram S.K."/>
<person name="Bickmore W.A."/>
<person name="Munro P.M.G."/>
<person name="Gal A."/>
<person name="Hamel C.P."/>
<person name="Marigo V."/>
<person name="Ponting C.P."/>
<person name="Wissinger B."/>
<person name="Zrenner E."/>
<person name="Matter K."/>
<person name="Swaroop A."/>
<person name="Koenekoop R.K."/>
<person name="Bhattacharya S.S."/>
</authorList>
<dbReference type="PubMed" id="17924349"/>
<dbReference type="DOI" id="10.1086/521953"/>
</citation>
<scope>INVOLVEMENT IN RP31</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="3918" last="3923">
<title>TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins.</title>
<authorList>
<person name="Pungaliya P."/>
<person name="Kulkarni D."/>
<person name="Park H.J."/>
<person name="Marshall H."/>
<person name="Zheng H."/>
<person name="Lackland H."/>
<person name="Saleem A."/>
<person name="Rubin E.H."/>
</authorList>
<dbReference type="PubMed" id="17803295"/>
<dbReference type="DOI" id="10.1021/pr0703674"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SIN3A</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Biochemistry" volume="47" first="13887" last="13896">
<title>Identification of phosphorylation sites of TOPORS and a role for serine 98 in the regulation of ubiquitin but not SUMO E3 ligase activity.</title>
<authorList>
<person name="Park H.J."/>
<person name="Zheng H."/>
<person name="Kulkarni D."/>
<person name="Kerrigan J."/>
<person name="Pungaliya P."/>
<person name="Saleem A."/>
<person name="Rubin E.H."/>
</authorList>
<dbReference type="PubMed" id="19053840"/>
<dbReference type="DOI" id="10.1021/bi801904q"/>
</citation>
<scope>PHOSPHORYLATION AT SER-98; SER-499; SER-585 AND SER-866</scope>
<scope>MUTAGENESIS OF SER-98</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="4834" last="4840">
<title>Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1.</title>
<authorList>
<person name="Guan B."/>
<person name="Pungaliya P."/>
<person name="Li X."/>
<person name="Uquillas C."/>
<person name="Mutton L.N."/>
<person name="Rubin E.H."/>
<person name="Bieberich C.J."/>
</authorList>
<dbReference type="PubMed" id="18077445"/>
<dbReference type="DOI" id="10.1074/jbc.M708630200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NKX3-1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="18588" last="18592">
<title>Plk1-mediated phosphorylation of Topors regulates p53 stability.</title>
<authorList>
<person name="Yang X."/>
<person name="Li H."/>
<person name="Zhou Z."/>
<person name="Wang W.H."/>
<person name="Deng A."/>
<person name="Andrisani O."/>
<person name="Liu X."/>
</authorList>
<dbReference type="PubMed" id="19473992"/>
<dbReference type="DOI" id="10.1074/jbc.C109.001560"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PLK1</scope>
<scope>PHOSPHORYLATION AT SER-718 BY PLK1</scope>
<scope>MUTAGENESIS OF SER-718</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98; SER-864 AND SER-866</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Mol. Cell" volume="37" first="503" last="515">
<title>SUMOylation-dependent localization of IKKepsilon in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death.</title>
<authorList>
<person name="Renner F."/>
<person name="Moreno R."/>
<person name="Schmitz M.L."/>
</authorList>
<dbReference type="PubMed" id="20188669"/>
<dbReference type="DOI" id="10.1016/j.molcel.2010.01.018"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IKBKE</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98; SER-864 AND SER-866</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98; SER-194; SER-585 AND SER-734</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-76; LYS-83; LYS-249 AND LYS-701</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-76 AND LYS-701</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.O114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-76 AND LYS-701</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-73; LYS-76; LYS-83; LYS-88; LYS-159; LYS-249; LYS-701; LYS-819 AND LYS-837</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<comment type="function">
<text evidence="18 20 21 22 24 26 27">Functions as an E3 ubiquitin-protein ligase and as an E3 SUMO1-protein ligase. Probable tumor suppressor involved in cell growth, cell proliferation and apoptosis that regulates p53/TP53 stability through ubiquitin-dependent degradation. May regulate chromatin modification through sumoylation of several chromatin modification-associated proteins. May be involved in DNA damage-induced cell death through IKBKE sumoylation.</text>
</comment>
<comment type="catalytic activity">
<text>S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
</comment>
<comment type="subunit">
<text evidence="11 13 14 16 22 24 26 27">Interacts with PARK7/DJ-1 (By similarity). Interacts with TOP1. Interacts with p53/TP53; can both ubiquitinate and sumoylate p53/TP53. Interacts with the SUMO1 conjugating enzyme UBE2I. Interacts with SUMO1. Interacts with NKX3-1; polyubiquitinates NKX3-1 and induces its proteasomal degradation. Interacts with SIN3A; sumoylates SIN3A. Interacts with IKBKE; induced by DNA damage.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1996473"/>
<interactant intactId="EBI-7387242">
<id>P03132</id>
<label>Rep68</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>PML body</location>
</subcellularLocation>
<text>Localizes to discrete nuclear foci which partly overlap with PML nuclear bodies. Targeted to PML nuclear bodies upon DNA damage.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9NS56-1</id>
<name>1</name>
<name>LUN-1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9NS56-2</id>
<name>2</name>
<name>LUN-2</name>
<sequence type="described" ref="VSP_017916 VSP_017917"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="14 15 17">Expressed at highest levels in testis and at lower levels in adrenal gland, bone marrow, brain, colon, heart, kidney, liver, muscle, ovary, pancreas, placenta, prostate, skeletal muscle, skin, small intestine, spleen, stomach, testis, thymus, thyroid and uterus. Expressed in the alveolar epithelium of the lung. Expression is commonly decreased in colon adenocarcinomas and lung cancers.</text>
</comment>
<comment type="induction">
<text evidence="20">By genotoxic agents such as cisplatin and camptothecin.</text>
</comment>
<comment type="PTM">
<text evidence="25 26">Phosphorylation at Ser-98 regulates the E3 ubiquitin-protein ligase activity but not the SUMO1-protein ligase activity. Phosphorylation at Ser-718 increases the E3 ubiquitin-protein ligase activity versus the SUMO1-protein ligase activity resulting in increased p53/TP53 ubiquitination and degradation.</text>
</comment>
<comment type="PTM">
<text evidence="16 21">Sumoylated.</text>
</comment>
<comment type="disease" evidence="23">
<disease id="DI-00991">
<name>Retinitis pigmentosa 31</name>
<acronym>RP31</acronym>
<description>A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.</description>
<dbReference type="MIM" id="609923"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="caution">
<text evidence="30">Was originally thought to bind to the palindromic consensus sequence 5'-TCCCAGCACTTTGGGA-3' and to regulate the transcription of numerous genes in the lung.</text>
</comment>
<comment type="sequence caution" evidence="29">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAC98530" version="1"/>
</conflict>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/TOPORSID42663ch9p21.html"/>
</comment>
<dbReference type="EC" id="2.3.2.27"/>
<dbReference type="EMBL" id="AF098300">
<property type="protein sequence ID" value="AAD23379.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB045732">
<property type="protein sequence ID" value="BAB03714.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB045733">
<property type="protein sequence ID" value="BAB03715.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL353671">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC060884">
<property type="protein sequence ID" value="AAH60884.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U82939">
<property type="protein sequence ID" value="AAC98530.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56566.1">
<molecule id="Q9NS56-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6527.1">
<molecule id="Q9NS56-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001182551.1">
<molecule id="Q9NS56-2"/>
<property type="nucleotide sequence ID" value="NM_001195622.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005793.2">
<molecule id="Q9NS56-1"/>
<property type="nucleotide sequence ID" value="NM_005802.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.589962"/>
<dbReference type="ProteinModelPortal" id="Q9NS56"/>
<dbReference type="SMR" id="Q9NS56"/>
<dbReference type="BioGrid" id="115505">
<property type="interactions" value="65"/>
</dbReference>
<dbReference type="IntAct" id="Q9NS56">
<property type="interactions" value="19"/>
</dbReference>
<dbReference type="MINT" id="MINT-94004"/>
<dbReference type="STRING" id="9606.ENSP00000353735"/>
<dbReference type="iPTMnet" id="Q9NS56"/>
<dbReference type="PhosphoSitePlus" id="Q9NS56"/>
<dbReference type="BioMuta" id="TOPORS"/>
<dbReference type="DMDM" id="74752935"/>
<dbReference type="EPD" id="Q9NS56"/>
<dbReference type="MaxQB" id="Q9NS56"/>
<dbReference type="PaxDb" id="Q9NS56"/>
<dbReference type="PeptideAtlas" id="Q9NS56"/>
<dbReference type="PRIDE" id="Q9NS56"/>
<dbReference type="Ensembl" id="ENST00000360538">
<molecule id="Q9NS56-1"/>
<property type="protein sequence ID" value="ENSP00000353735"/>
<property type="gene ID" value="ENSG00000197579"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000379858">
<molecule id="Q9NS56-2"/>
<property type="protein sequence ID" value="ENSP00000369187"/>
<property type="gene ID" value="ENSG00000197579"/>
</dbReference>
<dbReference type="GeneID" id="10210"/>
<dbReference type="KEGG" id="hsa:10210"/>
<dbReference type="UCSC" id="uc003zrb.4">
<molecule id="Q9NS56-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10210"/>
<dbReference type="DisGeNET" id="10210"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000197579.7"/>
<dbReference type="GeneCards" id="TOPORS"/>
<dbReference type="GeneReviews" id="TOPORS"/>
<dbReference type="HGNC" id="HGNC:21653">
<property type="gene designation" value="TOPORS"/>
</dbReference>
<dbReference type="HPA" id="HPA060640"/>
<dbReference type="HPA" id="HPA065661"/>
<dbReference type="MalaCards" id="TOPORS"/>
<dbReference type="MIM" id="609507">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="609923">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9NS56"/>
<dbReference type="OpenTargets" id="ENSG00000197579"/>
<dbReference type="Orphanet" id="791">
<property type="disease" value="Retinitis pigmentosa"/>
</dbReference>
<dbReference type="PharmGKB" id="PA134979531"/>
<dbReference type="eggNOG" id="KOG4430">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQZR">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000064170"/>
<dbReference type="HOGENOM" id="HOG000231723"/>
<dbReference type="HOVERGEN" id="HBG080410"/>
<dbReference type="InParanoid" id="Q9NS56"/>
<dbReference type="KO" id="K10631"/>
<dbReference type="OMA" id="FIHEFIS"/>
<dbReference type="OrthoDB" id="EOG091G089U"/>
<dbReference type="PhylomeDB" id="Q9NS56"/>
<dbReference type="TreeFam" id="TF339497"/>
<dbReference type="SIGNOR" id="Q9NS56"/>
<dbReference type="ChiTaRS" id="TOPORS">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="TOPORS"/>
<dbReference type="GenomeRNAi" id="10210"/>
<dbReference type="PRO" id="PR:Q9NS56"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000197579"/>
<dbReference type="CleanEx" id="HS_TOPORS"/>
<dbReference type="Genevisible" id="Q9NS56">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005814">
<property type="term" value="C:centriole"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0036064">
<property type="term" value="C:ciliary basal body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000930">
<property type="term" value="C:gamma-tubulin complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030496">
<property type="term" value="C:midbody"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032391">
<property type="term" value="C:photoreceptor connecting cilium"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000922">
<property type="term" value="C:spindle pole"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000151">
<property type="term" value="C:ubiquitin ligase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003823">
<property type="term" value="F:antigen binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044547">
<property type="term" value="F:DNA topoisomerase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019789">
<property type="term" value="F:SUMO transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008630">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042771">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051457">
<property type="term" value="P:maintenance of protein location in nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035845">
<property type="term" value="P:photoreceptor cell outer segment organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051443">
<property type="term" value="P:positive regulation of ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070936">
<property type="term" value="P:protein K48-linked ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034504">
<property type="term" value="P:protein localization to nucleus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006513">
<property type="term" value="P:protein monoubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016925">
<property type="term" value="P:protein sumoylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010842">
<property type="term" value="P:retina layer formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046549">
<property type="term" value="P:retinal cone cell development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046548">
<property type="term" value="P:retinal rod cell development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR017907">
<property type="entry name" value="Znf_RING_CS"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00518">
<property type="entry name" value="ZF_RING_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0682">Retinitis pigmentosa</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="E3 ubiquitin-protein ligase Topors" id="PRO_0000232626">
<location>
<begin position="1"/>
<end position="1045"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="12">
<location>
<begin position="103"/>
<end position="142"/>
</location>
</feature>
<feature type="region of interest" description="E3 ubiquitin-protein ligase activity">
<location>
<begin position="1"/>
<end position="195"/>
</location>
</feature>
<feature type="region of interest" description="Required for DNA-binding">
<location>
<begin position="51"/>
<end position="374"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SUMO1" evidence="16">
<location>
<begin position="437"/>
<end position="654"/>
</location>
</feature>
<feature type="region of interest" description="Required for sumoylation and localization to discrete nuclear foci">
<location>
<begin position="437"/>
<end position="574"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TOP1" evidence="13">
<location>
<begin position="456"/>
<end position="882"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with p53/TP53" evidence="14">
<location>
<begin position="456"/>
<end position="731"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with UBE2I" evidence="16">
<location>
<begin position="854"/>
<end position="917"/>
</location>
</feature>
<feature type="compositionally biased region" description="Arg-rich">
<location>
<begin position="579"/>
<end position="788"/>
</location>
</feature>
<feature type="compositionally biased region" description="Lys-rich">
<location>
<begin position="854"/>
<end position="895"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 2 3 4 5 6 25">
<location>
<position position="98"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="194"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="499"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 25">
<location>
<position position="585"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PLK1" evidence="26">
<location>
<position position="718"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="734"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 4">
<location>
<position position="864"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 4 25">
<location>
<position position="866"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="912"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="914"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="1028"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="10">
<location>
<position position="73"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7 8 9 10">
<location>
<position position="76"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7 10">
<location>
<position position="83"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="10">
<location>
<position position="88"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="10">
<location>
<position position="159"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7 10">
<location>
<position position="249"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)">
<location>
<position position="560"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7 8 9 10">
<location>
<position position="701"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="10">
<location>
<position position="819"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="10">
<location>
<position position="837"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_017916" evidence="28">
<location>
<begin position="1"/>
<end position="65"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_017917" evidence="28">
<original>E</original>
<variation>M</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17855104." id="VAR_037629" evidence="19">
<original>A</original>
<variation>T</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17855103." id="VAR_037630" evidence="19">
<original>E</original>
<variation>K</variation>
<location>
<position position="517"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17857515." id="VAR_037631" evidence="19">
<original>N</original>
<variation>D</variation>
<location>
<position position="749"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs36034138." id="VAR_037632">
<original>P</original>
<variation>R</variation>
<location>
<position position="812"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on sumoylation." evidence="16">
<original>K</original>
<variation>R</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation but no effect on E3 ubiquitin-protein ligase activity." evidence="25">
<original>S</original>
<variation>A</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increase in E3 ubiquitin-protein ligase activity and increased binding to UBE2D1. No effect on SUMO1-protein ligase activity." evidence="25">
<original>S</original>
<variation>D</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates E3 ubiquitin-protein ligase activity." evidence="18">
<original>W</original>
<variation>A</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on sumoylation." evidence="16">
<original>K</original>
<variation>R</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on sumoylation." evidence="16">
<original>K</original>
<variation>R</variation>
<location>
<position position="485"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces sumoylation." evidence="16">
<original>K</original>
<variation>R</variation>
<location>
<position position="560"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by PLK1 and increases in p53/TP53 stability." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="718"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on sumoylation." evidence="16">
<original>K</original>
<variation>R</variation>
<location>
<position position="921"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAC98530." ref="5" evidence="29">
<original>CF</original>
<variation>K</variation>
<location>
<begin position="124"/>
<end position="125"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD23379." ref="1" evidence="29">
<original>N</original>
<variation>S</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD23379." ref="1" evidence="29">
<original>F</original>
<variation>S</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD23379." ref="1" evidence="29">
<original>E</original>
<variation>G</variation>
<location>
<position position="922"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD23379." ref="1" evidence="29">
<original>R</original>
<variation>K</variation>
<location>
<position position="1040"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q80Z37"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10352183"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10415337"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11278651"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14516784"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15107820"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15247280"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15735665"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16122737"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17803295"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17924349"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18077445"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19053840"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19473992"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20188669"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11278651"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305"/>
<evidence key="30" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11278651"/>
</source>
</evidence>
<sequence length="1045" mass="119198" checksum="3DA635FDB5C83B77" modified="2000-10-01" version="1">
MGSQPPLGSPLSREEGEAPPPAPASEGRRRSRRVRLRGSCRHRPSFLGCRELAASAPARP
APASSEIMASAAKEFKMDNFSPKAGTSKLQQTVPADASPDSKCPICLDRFDNVSYLDRCL
HKFCFRCVQEWSKNKAECPLCKQPFDSIFHSVRAEDDFKEYVLRPSYNGSFVTPDRRFRY
RTTLTRERNASVYSPSGPVNRRTTTPPDSGVLFEGLGISTRPRDVEIPQFMRQIAVRRPT
TADERSLRKIQEQDIINFRRTLYRAGARVRNIEDGGRYRDISAEFFRRNPACLHRLVPWL
KRELTVLFGAHGSLVNIVQHIIMSNVTRYDLESQAFVSDLRPFLLNRTEHFIHEFISFAR
SPFNMAAFDQHANYDCPAPSYEEGSHSDSSVITISPDEAETQELDINVATVSQAPWDDET
PGPSYSSSEQVHVTMSSLLNTSDSSDEELVTGGATSQIQGVQTNDDLNNDSDDSSDNCVI
VGFVKPLAERTPELVELSSDSEDLGSYEKMETVKTQEQEQSYSSGDSDVSRCSSPHSVLG
KDEQINKGHCDSSTRIKSKKEEKRSTSLSSPRNLNSSVRGDRVYSPYNHRHRKRGRSRSS
DSRSQSRSGHDQKNHRKHHGKKRMKSKRSRSRESSRPRGRRDKKRSRTRDSSWSRRSQTL
SLSSESTSRSRSRSSDHGKRRSRSRNRDRYYLRNNYGSRYKWEYTYYSRNKDRDGYESSY
RRRTLSRAHYSRQSSSPEFRVQSFSERTNARKKNNHSERKYYYYERHRSRSLSSNRSRTA
STGTDRVRNEKPGGKRKYKTRHLEGTNEVAQPSREFASKAKDSHYQKSSSKLDGNYKNES
DTFSDSRSSDRETKHKRRKRKTRSLSVEIVYEGKATDTTKHHKKKKKKHKKKHKKHHGDN
ASRSPVVITIDSDSDKDSEVKEDTECDNSGPQDPLQNEFLAPSLEPFETKDVVTIEAEFG
VLDKECDIATLSNNLNNANKTVDNIPPLAASVEQTLDVREESTFVSDLENQPSNIVSLQT
EPSRQLPSPRTSLMSVCLGRDCDMS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>